Format
Sort by

Send to

Choose Destination

Links from Books

Items: 5

1.

Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers.

LeMaistre CF, Craig FE, Meneghetti C, McMullin B, Parker K, Reuben J, Boldt DH, Rosenblum M, Woodworth T.

Cancer Res. 1993 Sep 1;53(17):3930-4.

2.

Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma.

Hesketh P, Caguioa P, Koh H, Dewey H, Facada A, McCaffrey R, Parker K, Nylen P, Woodworth T.

J Clin Oncol. 1993 Sep;11(9):1682-90.

PMID:
8355035
3.

Diphtheria toxin-related cytokine fusion proteins: elongation factor 2 as a target for the treatment of neoplastic disease.

vanderSpek J, Cosenza L, Woodworth T, Nichols JC, Murphy JR.

Mol Cell Biochem. 1994 Sep;138(1-2):151-6.

PMID:
7898459
4.

Iron, DtxR, and the regulation of diphtheria toxin expression.

Tao X, Schiering N, Zeng HY, Ringe D, Murphy JR.

Mol Microbiol. 1994 Oct;14(2):191-7. Review.

PMID:
7830565
5.

Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden.

Rappuoli R, Perugini M, Falsen E.

N Engl J Med. 1988 Jan 7;318(1):12-4.

PMID:
2827023

Supplemental Content

Support Center